Followers | 170 |
Posts | 9931 |
Boards Moderated | 5 |
Alias Born | 06/20/2022 |
Wednesday, July 06, 2022 10:14:35 AM
"The HYLA(TM) non-invasive blood sensor is attached to the outer walls of a tube that has blood flowing through it." (Quoted in relevant part; emphases added.)
https://www.prnewswire.com/news-releases/inspira-technologies-develops-a-non-invasive-blood-sensor-designed-to-alert-real-time-change-in-patients---potentially-targets-2-5-billion-abg-market-301581383.html
As you can see from their OWN (so-called) "groundbreaking" nonsense, an INVASIVE "TUBE" must first be inserted INTO the patients in question BEFORE any monitoring, testing, etc., of their BLOOD is accomplished. Do NOT be scammed by this scamming Company!!!
Recent IINN News
- Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 • PR Newswire (US) • 04/25/2024 12:00:00 PM
- Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures • PR Newswire (US) • 04/16/2024 12:42:00 PM
- Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections • PR Newswire (US) • 04/10/2024 12:24:00 PM
- Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb • PR Newswire (US) • 04/03/2024 12:30:00 PM
- Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Inspira™ Technologies Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/25/2024 01:20:00 PM
- Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets • PR Newswire (US) • 03/18/2024 11:00:00 AM
- Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator • PR Newswire (US) • 03/12/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 09:01:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 09:01:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 02:25:02 PM
- Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days • PR Newswire (US) • 03/04/2024 02:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/27/2024 12:15:04 PM
- Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone • PR Newswire (US) • 02/27/2024 12:02:00 PM
- Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements • PR Newswire (US) • 02/27/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/22/2024 02:18:17 PM
- Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies • PR Newswire (US) • 02/22/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 02:18:42 PM
- Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System • PR Newswire (US) • 02/14/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:09 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 02:15:03 PM
- Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device • PR Newswire (US) • 02/08/2024 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2024 01:40:02 PM
- Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices • PR Newswire (US) • 01/30/2024 01:30:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM